Brugada Syndrome Market, By Disease Classification (Type 1 Brugada Syndrome, Type 2 Brugada Syndrome, and Type 3 Brugada Syndrome), By Product Type (Implantable Cardioverter-Defibrillators (ICDs), Pharmacological Therapy, Catheter Ablation Equipment, Genetic Testing Kits and Reagents, AI-ECG Software, Wearable ECG Monitors, and Other (Holter)), By Diagnostic Modality (Resting Electrocardiogram (ECG), Provocation Testing (Sodium Channel Blocker Tests), Genetic Testing, and Electrophysiology Study (EPS)), By Age Group (Pediatric, Adult, and Geriatric), By Gender (Male and Female), By End User (Hospitals, Specialty Cardiac Centers, Diagnostic and Genetic Testing Laboratories, Home/Remote Care Providers, and Research and Academic Institutes), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)